Visceral sensitivity: pathophysiological role and therapeutic advances in functional bowel disorders

被引：0
|
作者：
Delvaux, M [1 ]
Frexinos, J [1 ]
机构：
[1] CHU Rangueil, Serv Gastroenterol & Nutr, F-31403 Toulouse 4, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2001年 / 25卷
关键词：
functional bowel disorders; visceral sensitivity; brain-gut axis; irritable bowel syndrome;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
ANATOMICAL BASIS OF DIGESTIVE SENSITIVITY NEUROMEDIATORS PHYSIOLOGY OF DIGESTIVE AFFERENT NERVE PATHWAYS VISCERAL HYPERSENSITIVITY AND IRRITABLE BOWEL SYNDROME Clinical concept of visceral hypersensitivity Methods for measurement of hypersensitivity in patients with irritable bowel syndrome Factors influencing measurements of sensory thresholds Aetiology of hypersensitivity in patients with irritable bowel syndrome THERAPEUTIC PERSPECTIVES Substances acting on serotonine receptors 5-HT3 receptor antagonists 5-HT4 receptor antagonists Fedotozine, an agonist of peripheral opioid K receptors Other neurotransmitters CONCLUSION
引用
收藏
页码：C42 / C53
页数：12
相关论文
共 50 条
  • [11] Brain functional connectivity is associated with visceral sensitivity in women with Irritable Bowel Syndrome
    Icenhour, Adriane
    Witt, Suzanne T.
    Elsenbruch, Sigrid
    Lowen, Mats
    Engstrom, Maria
    Tillisch, Kirsten
    Mayer, Emeran A.
    Walter, Susanna
    [J]. NEUROIMAGE-CLINICAL, 2017, 15 : 449 - 457
  • [12] FUNCTIONAL DYSPEPSIA - RECENT PATHOPHYSIOLOGICAL ADVANCES
    AZPIROZ, F
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 1990, 53 (5-6): : 518 - 522
  • [13] Enteric alpha-2 adrenoceptors: Pathophysiological implications in functional and inflammatory bowel disorders
    Blandizzi, Corrado
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2007, 51 (05) : 282 - 288
  • [14] DIGESTIVE GAS - PATHOPHYSIOLOGY AND THERAPEUTIC APPROACH IN FUNCTIONAL BOWEL DISORDERS
    CLOAREC, D
    FLOURIE, B
    MARTEAU, P
    GALMICHE, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (8-9): : 641 - 650
  • [15] Visceral pain processing in patients with painfull or painless functional bowel disorders.
    Bouin, M
    Poitras, P
    Boivin, M
    Laganiere, M
    Devroede, G
    Plourde, V
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A637 - A637
  • [16] An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma
    Seo, Seung-Hee
    Paul, Shamrat Kumar
    Shikder, Mita
    Khanam, Mushira
    Ghosh, Popy
    Al Hasib, Tasnin
    Ahmed, Kazi Ahsan
    Sikdar, Suranjana
    Uddin, Md Jamal
    Kwon, Youngjoo
    [J]. CANCERS, 2021, 13 (13)
  • [17] Role of enteric infections and inflammation in functional bowel disorders
    Piche, T
    Collins, SM
    Rampal, P
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (6-7): : 624 - 629
  • [18] Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain
    Holzer, P
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 429 (1-3) : 177 - 193
  • [19] New treatments and therapeutic targets for IBS and other functional bowel disorders
    Simren, Magnus
    Tack, Jan
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (10) : 589 - 605
  • [20] New treatments and therapeutic targets for IBS and other functional bowel disorders
    Magnus Simrén
    Jan Tack
    [J]. Nature Reviews Gastroenterology & Hepatology, 2018, 15 : 589 - 605
12345